Forte Biosciences, Inc. (FBRX)

Forte Biosciences Statistics

Total Valuation

FBRX has a market cap or net worth of $124.28 million. The enterprise value is $78.42 million.

Market Cap	124.28M
Enterprise Value	78.42M

Important Dates

The next estimated earnings date is Monday, August 18, 2025, after market close.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

FBRX has 12.21 million shares outstanding. The number of shares has increased by 250.48% in one year.

Current Share Class	12.21M
Shares Outstanding	12.21M
Shares Change (YoY)	+250.48%
Shares Change (QoQ)	+86.03%
Owned by Insiders (%)	4.57%
Owned by Institutions (%)	45.17%
Float	10.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.74
P/TBV Ratio	3.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.22

Current Ratio	5.22
Quick Ratio	5.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -130.27% and return on invested capital (ROIC) is -83.67%.

Return on Equity (ROE)	-130.27%
Return on Assets (ROA)	-70.65%
Return on Invested Capital (ROIC)	-83.67%
Return on Capital Employed (ROCE)	-116.90%
Revenue Per Employee	n/a
Profits Per Employee	-$3.12M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.43% in the last 52 weeks. The beta is 2.91, so FBRX's price volatility has been higher than the market average.

Beta (5Y)	2.91
52-Week Price Change	-13.43%
50-Day Moving Average	11.21
200-Day Moving Average	11.20
Relative Strength Index (RSI)	46.48
Average Volume (20 Days)	58,193

Short Selling Information

The latest short interest is 128,031, so 1.05% of the outstanding shares have been sold short.

Short Interest	128,031
Short Previous Month	135,933
Short % of Shares Out	1.05%
Short % of Float	1.26%
Short Ratio (days to cover)	0.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.92M
Pretax Income	-32.14M
Net Income	-43.71M
EBITDA	-44.88M
EBIT	-44.92M
Earnings Per Share (EPS)	-$8.24

Balance Sheet

The company has $45.86 million in cash and n/a in debt, giving a net cash position of $45.86 million or $3.75 per share.

Cash & Cash Equivalents	45.86M
Total Debt	n/a
Net Cash	45.86M
Net Cash Per Share	$3.75
Equity (Book Value)	38.43M
Book Value Per Share	5.84
Working Capital	38.13M

Cash Flow

In the last 12 months, operating cash flow was -$34.43 million and capital expenditures -$92,000, giving a free cash flow of -$34.53 million.

Operating Cash Flow	-34.43M
Capital Expenditures	-92,000
Free Cash Flow	-34.53M
FCF Per Share	-$2.83

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-250.48%
Shareholder Yield	-250.48%
Earnings Yield	-35.18%
FCF Yield	-27.78%

Analyst Forecast

The average price target for FBRX is $61.00, which is 499.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$61.00
Price Target Difference	499.51%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Aug 28, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1